Tuesday, May 31, 2016

Daiichi Sankyo to not proceed with lung cancer study

… its late-stage study on the lung cancer drug, patritumab.This decision on …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)